FOCUSED ON DEVELOPMENT OF ADVANCED SOLUTIONS FOR REGENERATIVE SURGICAL PATCHES AND ADHESIVES

CLINICAL TIMELINE

Nurami Medical is focused on developing revolutionary formulations to combat limitations found in existing surgical sealants and adhesives.  These formulations are based on Nurami’s novel approach combining nanofibers and advanced bioactive materials which enhance healing and regeneration.

Nurami’s preliminary product is ArtiFascia, a highly effective surgical patch with integrated temperature sensitive sealant, which will be market ready in 2022.  Our pipeline incudes NanoFibreX, a soft tissue sealant patch which does not require suturing and a groundbreaking surgical adhesive for general surgery which will withstand premature degradation while adhering effectively to the wet environment of internal organs.

Product

Surgery
Type

Device
Development

Preclinical
Studies

Pilot Clinical
Trials

Pivotal Clinical
Trials

Regulatory
Clearance

Commercialization

Neurosurgery

ArtiFascia

FDA and
CE in 2021

2020

NanofibreX

Neuro &
general surgery

2021

Nurami
Surgical Adhesive

General
surgery

Product

Neurosurgery

NanofibreX

Nurami
Surgical Adhesive

Surgery
Type

ArtiFascia

Neuro &
general surgery

General
surgery

Device
Development

Preclinical
Studies

Pilot Clinical
Trials

2021

Pivotal Clinical
Trials

Pivotal Clinical
Trials

Regulatory
Clearance

FDA and
CE in 2021

Commercia-
lization

2020